RxDoctor Payments DataLook up a doctor →

Darin Checketts, DO

Internal Medicine · Layton, UTNPI 1639158512

Payments from drug & device makers

$58,108in general payments, 2019–2025

Across 735 payments — averaging $79.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Akebia Therapeutics Inc$47K
  • Novo Nordisk$1K
  • Boehringer Ingelheim$1K
  • AbbVie$929
  • AstraZeneca$850
  • Astellas Pharma US Inc$828
  • plus $6K from 50 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Akebia Therapeutics Inc27$46,903
Novo Nordisk112$1,287
Boehringer Ingelheim55$1,019
AbbVie(2 entities)51$929
AstraZeneca40$850
Astellas Pharma US Inc47$828
Amgen48$754
Lilly USA, LLC49$649
GSK41$646
Pfizer27$408
Novartis17$330
Johnson & Johnson21$291
Abbott18$272
Sanofi-aventis U.S. LLC20$264
Amarin Pharma, Inc.17$264
Takeda Pharmaceuticals U.S.A., Inc.12$241
Dexcom, Inc.13$218
E.r. Squibb & Sons, L.L.C.12$179
Sumitomo Pharma America, Inc.10$137
Mylan Specialty L.p.6$126
Idorsia Pharmaceuticals US Inc6$91
Biohaven Pharmaceutical Holding Company Ltd.5$85
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$85
Daiichi Sankyo Inc.4$85
Axsome Therapeutics, Inc.5$84
Lundbeck LLC5$80
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC5$78
Medtronic(2 entities)5$74
Sunovion Pharmaceuticals Inc.5$66
Eisai Inc.5$63
Supernus Pharmaceuticals, Inc.3$58
Exact Sciences3$50
Dynavax Technologies Corporation3$49
Tandem Diabetes Care, Inc.3$49
Insulet Corporation2$41
Genentech USA, Inc.3$39
Biogen2$32
Vistapharm, Inc.2$32
Phathom Pharmaceuticals, Inc.2$32
Inspire Medical Systems, Inc.2$29
Edwards Lifesciences1$27
Merck2$25
Viatris Specialty LLC1$25
Corcept Therapeutics2$24
Otsuka America Pharmaceutical, Inc.1$24
Seqirus USA Inc1$21
Nestle Healthcare Nutrition Inc.1$20
Teva Pharmaceuticals USA, Inc.1$19
Biohaven Pharmaceuticals, Inc.1$19
Shire North American Group Inc1$19
Xeris Pharmaceuticals, Inc.1$17
Shield Therapeutics Inc1$15
Lucid Diagnostics Inc.1$15
Jazz Pharmaceuticals Inc.1$14
Lifescan, Inc.1$13
Kowa Pharmaceuticals America, Inc.1$12

How this compares

$58,108 in reported general payments places this provider in the 95th percentile of 496 internal medicine providers in Utah.

See all internal medicine providers in Utah →

Medicare billing

Part B allowed, 2024
$208,398
Medicare patients
412
Services billed
6,894

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Layton

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →